NCT00408070View on ClinicalTrials.gov

Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

October 31, 2009

Conditions
Ovarian CancerPeritoneal CancerFallopian Tube CancerStage 3 CancerStage 4 Cancer
Interventions
DRUG

Bevacizumab

cycle 2 (6 cycles re-evaluated and follow up)

DRUG

Carboplatin

cycle #1 and continuous through entire regimen; treated every 3 weeks

DRUG

Paclitaxel

cycle #1 and continuous through entire regimen; treated every 3 weeks

Trial Locations (1)

06030

University of Connecticut Health Center, Farmington

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

UConn Health

OTHER